MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 09-05-2025
Phreesia Total Assets 2011-2026 | PHR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Phreesia
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 370 M | 370 M | 494 M | 327 M | 159 M | 59.3 M | 57.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 494 M | 57.1 M | 262 M |
Quarterly Total Assets Phreesia
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 409 M | 400 M | 376 M | - | 372 M | 375 M | 340 M | 354 M | 370 M | 397 M | 426 M | 459 M | 327 M | 529 M | 551 M | 561 M | 159 M | 338 M | 160 M | 161 M | 59.3 M | 156 M | 163 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 561 M | 59.3 M | 338 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
324 M | $ 5.52 | 1.1 % | $ 88.6 M |  USA |
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
HealthStream
HSTM
|
511 M | $ 21.86 | -0.86 % | $ 664 M | USA |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 3.35 | -5.77 % | $ 314 M | USA |
 |
HealthEquity
HQY
|
3.16 B | $ 80.0 | -1.42 % | $ 6.85 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
So-Young International
SY
|
2.74 B | $ 2.91 | 1.04 % | $ 231 M |  China |
 |
MTBC
MTBC
|
71.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 41.91 | 0.92 % | $ 1.93 B | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.28 | 4.59 % | $ 879 M | USA |
 |
Health Catalyst
HCAT
|
859 M | $ 1.92 | -1.79 % | $ 116 M | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Progyny
PGNY
|
607 M | $ 17.61 | -1.01 % | $ 1.51 B | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 7.66 | -2.67 % | $ 131 M | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
726 M | $ 12.96 | -1.26 % | $ 952 M | USA |
 |
Teladoc Health
TDOC
|
2.86 B | $ 5.11 | -0.49 % | $ 900 M | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 1.71 | 2.4 % | $ 8.9 M | China |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
10x Genomics
TXG
|
965 M | $ 21.85 | -2.32 % | $ 2.56 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
5.91 B | $ 195.36 | 3.65 % | $ 31.4 B | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.13 | -4.02 % | $ 190 K | USA |